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CLINICAL INVESTIGATION
Childhood nephrotic syndrome associated with diffuse
mesangial hypercellularity. A report of the Southwest Pediatric
Nephrology Study Group1
Childhood nephrotic syndrome associated with diffuse mesangial hy-
percellularity. A report of the Southwest Pediatric Nephrology Study
Group. Clinico-pathologic correlations and therapeutic responses were
examined in 29 children with idiopathic nephrotic syndrome (INS) and
diffuse mesangial hypercellularity (DMH). At the onset of INS, micro-
scopic hematuria was noted in 89%, hypertension in 46%, and impaired
renal function in 24% of patients. Semiquantitative grading of the renal
histopathology revealed mild (1+), moderate (2+), and severe (3+)
grades of DMH in 13, 11, and 5 patients, respectively. Higher grades of
DMH were associated with glomerular electron dense deposits and
severe hematuria. Twelve of 24 steroid-treated patients had complete
remissions of INS, and three had partial remissions. Of the nine patients
resistant to steroid therapy, six received chlorambucil or cyclophospha-
mide but none responded. Resistance to steroids was associated with
more severe DMH and the presence of glomerular electron dense
deposits. The presence of positive immunofluorescence was unrelated
to steroid responsiveness or outcome. After a mean follow-up of 29
months, proteinuria was present in ten of 26 patients but only two had
impaired renal function. Our limited follow-up of these patients with
INS and DMH suggests that initial response to steroid therapy is a
better indicator of subsequent clinical course than the degree of DMH.
Syndrome néphrotique de l'enfant associé a une hypercellularité me-
sangiale diffuse. Le rapport du Southwest Pediatric Nephrologic Study
Group. Les correlations clinico-pathologiques et les réponses thérapeu-
tiques ont été examinées chez 29 enfants avec un syndrome néphrotique
idiopathique (INS) et une hypercellularité mesangiale diffuse (DMH).
Au debut de l'INS, une hématurie microscopique était notée chez 89%,
une hypertension chez 46%, et une alteration de Ia fonction rCrale chez
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24% des malades. Une gradation semiquantitative de l'histopathologie
rCnale a révélé des stades discrets (1+), modérés (2+), et sévères (3+)
de DMH chez 13, 11, et 5 malades, respectivement. Des degres plus
élevés de DMH Ctaient associés avec des dépôts glomerulaires denses
aux electrons, et une hématurie sévère. Douze de 24 malades traités par
des stdroIdes ont eu une remission complete de l'INS, et trois ant eu des
remissions partielles. Des neuf malades résistants au traitement stéroI-
dien, six ont recu du chloambucil ou du cyclophosphamide, mais aucun
n'a répondu. La résistance aux stdroIdes était associée avec une DMH
plus sCvére, et a Ia presence de dCpôts glonjerulaires denses aux
Clectrons. La presence d'une immunofluorescence positive n'était pas
reliCe a Ia reponse aux stéroIdes ni a l'évolution. Après un suivi moyen
de 29 mois, Ia protéinurie ëtait présente chez dix des 25 malades, mais
seulement deux avaient une fonction rénale altérée. Notre suivi lirnité
de ces malades avec INS et DMH suggère que Ia réponse initiale au
traitement stéroide est un meilleur indicateur de l'Cvolution clinique
ultCrieure que le degre de DMH.
Most children with the idiopathic nephrotic syndrome (INS)
have minimal renal histologic abnormalities and respond satis-
factorily to steroid therapy [1]. Once considered a histopatho-
logic variant of minimal change nephrotic syndrome (MCNS),
the renal lesion of focal segmental glomeruloscierosis (FSGS)
was observed to have an unsatisfactory response to therapy in a
majority of patients, with deterioration of renal function in
some [2]. The clinical course of FSGS, therefore, was quite
unlike that of most patients with MCNS. Segregating FSGS has
led to the recognition of decreased morbidity and more consist-
ent steroid responsiveness in the remaining patients with INS.
Such clinicopathologic correlations have become important in
the initial counseling of parents of nephrotic children.
More recently another histopathologic pattern, thought by
some to be a variant of MCNS, that is characterized histologi-
cally by diffuse glomerular mesangial hypercellularity (DMH)
[2—11] and clinically by an increased incidence of hematuria,
has been reported in a few series to have a less favorable
response to steroid therapy. Most previous studies of the INS
with DMH have originated from single institutions, have includ-
ed only a few patients, have lacked rigid histologic criteria for
the degree of mesangial hypercellularity, and have not included
ultrastructural or immunofluorescence studies in most of their
patients. To critically re-examine INS with DMH, we as
members of the Southwest Pediatric Nephrology Study Group
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Table 1. Clinical and pathologic features assessed in patients with idiopathic nephrotic syndrome and diffuse mesangial hypercellularity
Initial clinical data Pathologic features Subsequent clinical data
Response
1. Age at presentation I. Grade of DMH (1 + —p 3+) 1. Response of proteinuria to steroids
2. Sex 2. Tubulo-interstitial damage (0— or 2. Response of proteinuria to
3. Race 3+) cyclophosphamide
4. Blood pressure 3. Immunofluorescence (+ or 3. Response of proteinuria to chlorambucil
5. Severity of edema 4. Glomerularelectrondensedeposits
6. Serum creatinine (+ or —) Data at latest assessment
7. Creatinine clearance I. Age
8. BUN 2. Total duration of follow-up
9. Total serum protein 3. Blood pressure
10. Serum albumin 4. Edema
11. Serum cholesterol 5. Serum creatinine
12. Serum C3 6. Creatinine clearance
13. Hematuria, severity 7. Hematuria
14. Proteinuna, dipstick 8. Proteinuria—dipstick
15. Proteinuria, quantitative
The presence of specific immunoglobulins, C3, FRA, and so forth, was also reviewed but was present in too few patients to warrant statistical
analysis.
(SPNSG) have compiled data on the largest series of children
with this disorder reported to date to our knowledge. The aims
of our study were (1) to evaluate the presentation and initial
clinical course of children with INS and DMH and (2) to grade
in a standardized and semiquantitative fashion the degree of
DMH and other histologic changes to seek clinico-pathologic
correlations which could aid in predicting the subsequent
clinical course of individual patients.
Methods
Clinical and laboratory studies. Patients were accepted into
the study if they presented with nephrotic syndrome and had a
renal biopsy specimen that demonstrated DMH without FSGS.
Clinical or laboratory evidence of postinfectious glomerulone-
phritis, systemic lupus erythematosus or Henoch-Schönlein
purpura excluded patients from the study. The nephrotic syn-
drome was defined as edema associated with heavy proteinuria
(> 40 mglm2/hr;  2+ qualitative proteinuria by dipstick; or
urinary protein to creatinine ratio > 1.0) with or without a
serum albumin < 2.5 gldl.
Medical records of patients accepted into the study were
reviewed carefully after DMH was confirmed by three patholo-
gists of the SPNSG. Clinical and laboratory data collected for
statistical analysis are shown in Table 1. The degree of hematu-
na was assessed by dipstick, which corresponded with micro-
scopic urinalysis for red blood cells as follows: negative, < 5
RBC/hpf; small, 5 to 20 RBC/hpf; moderate, 20—50 RBCIhpf;
and large, > 50 RBC/hpf.
Complete remission of the nephrotic syndrome was defined
as the disappearance of proteinuria for 3 consecutive days as
assessed by dipstick; partial remission, as a reduction to 50% or
less of the initial quantitative urinary protein excretion; and no
remission, as persistent urinary protein excretion of more than
50% of the original amount. Relapse was defined as urinary
protein excretion sufficient for the physician to recommend
daily steroid therapy at full dosage, that is, greater than 2+
proteinuria for more than 3 consecutive days.
Pathologic studies. All renal biopsy specimens from patients
with INS and DMH were reviewed by the pathologists from the
participating institutions. The renal tissue samples had been
fixed in either Duboscq-Brasil, Zenker's, or 10% formalin
solution, embedded in either paraffin or plastic, and cut into
thin sections (2 to 4 i) by routine methods at each participating
institution. Sections were stained with hematoxylin and eosin,
periodic acid-Schiff, and usually with silver methenamine and
Masson's trichrome. All were examined by the institutional
pathologists in conjunction with the original diagnostic biopsy
report. Selected slides (range 2 to 20; mean 7) were re-examined
by two principal reviewing pathologists to allow acceptance of a
patient and to determine the classification of each biopsy into
one of the three histologic subgroups of DMH described below.
The number of glomeruli examined in each case ranged from 6
to 77 (mean of 24) with 28 out of 29 of the biopsy specimens
containing ten or more glomeruli.
Individual histopathologic features in the glomeruli were
assessed with the degree of mesangial cellularity and mesangial
matrix as the main focus. In addition, the presence of glomeru-
lar obsolescence, necrosis, capillary loop thickening, splitting,
or crescent formation was noted. The system for grading
mesangial hypercellularity was modified from Murphy, Juk-
kola, and Roy [6]. The mesangial area was considered to be
the tissue between glomerular capillary loops. The lesions were
regarded as "diffuse" when all or nearly all ( 80%) glomeruli
in the biopsy specimen showed hypercellularity [14]. At least
75% of the peripheral mesangial areas of each glomerulus had to
show hypercellularity for the diagnosis of DMH to be con-
firmed; regions involving the vascular pole were not consid-
ered. A semiquantitative grading system was used: 1+, three
cell nuclei per mesangial area (Fig. 1); 2+, four cell nuclei per
mesangial area (Fig. 2); and 3+, five or more cell nuclei per
mesangial area (Fig. 3). Allowance was made for the variation
in slide thickness among biopsy specimens.
Histopathologic features of the tubules, interstitium, and
blood vessels were also assessed using a semiquantitative
grading system [12]. Tubular changes such as dilatation, atro-
phy, or basement membrane thickening were recorded. Intersti-
tial fibrosis, inflammation, or edema and arteriolar sclerosis
were also noted.
The immunofluorescence (IF) findings were recorded from
the original biopsy report (sometimes accompanied by photo-
Fig. 1. Light micrograph showing 1+ diffuse
meson gial hypercellularity. Three nuclei are
present in 75% of the mesangial areas.
(periodic acid-Schiff x 50O)
Fig. 2. Light micrograph showing 2 +
mesangial hypercellularity. Four nuclei are
present in 75% of the mesangial areas.
(periodic acid-Schiff x 500)
Fig. 3. Light micrograph showing 3+
mesangial hypercellularity. Five or more
nuclei are present in 75% of the mesangial
areas. (periodic acid-Schiff x500)
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Age in years at time of biopsy
graphic documentation). The tissues were snap-frozen and
direct IF was performed. Immunoreactants used included IgG,
IgA, 1gM, C3, fibrin(ogen)-related antigens (FRA), and albu-
min; in some centers, C4 and properdin were studied. Particular
attention was given to the presence or absence, location and
intensity of IF staining. In this retrospective study, no attempt
to standardize the IF antisera was possible although standard
techniques were used and the majority of institutions utilized
antisera from the same source (Meloy Lab, Inc., Springfield,
Virginia).
Electron microscopic findings were compiled from selected
prints and accompanying diagnostic reports. The tissue samples
were prepared and examined using standard techniques as
described previously [131. Particular attention was given to the
presence or absence of discrete glomerular electron-dense
"immune type" deposits (mesangial or capillary wall) and other
glomerular basement membrane changes.
Statistical methods. Correlations were sought between all the
clinical and pathologic features shown in Table 1 although only
significant correlations are reported. It must be remembered
that the statistically significant correlations must be viewed
with some caution given the small number of patients in
individual groups. Statistical methods utilized were Spearman
correlation co-efficients for the ordinal variables, and x2 contin-
gency table analysis or Fisher's exact probability test for the
association of categorical variables.
Results
Initial clinical and laboratory studies
Twenty-nine children (17 male; 12 female), whose ages at
clinical presentation of INS ranged from 1 year, 2 months, to 12
years, 7 months, (mean, 6 years, 7 months), were accepted for
the study (Fig. 4). Fourteen children were white, ten black, and
five Hispanic. Systolic and/or diastolic blood pressures were
elevated above the 95th percentile for age in 13 of 28 patients in
whom blood pressures were recorded. Edema of mild to
marked degree was observed in 26 of 27 patients in whom data
were available. Microscopic hematuria was observed in 25 of 28
patients (89%) recorded, and serum C3 determinations were
within normal limits in 25 of 26 patients tested. Elevated serum
creatinine for age or decreased creatinine clearances (< 90
ml/min/1.73 m2) were documented in seven patients (six males
and one female).
Clinical correlations. The only significant correlations among
the clinical variables listed in Table 1 were inverse relationships
between: age and hematuria (P = 0.01); serum protein concen-
tration and hematuria (P = 0.047); and serum concentrations of
albumin and cholesterol (P = 0.0012). A direct relationship was
observed between age and serum albumin concentrations (P =
0.001).
Pathologic studies
Renal biopsies were performed at the clinical presentation of
INS in 19 patients and at 1 month (four patients), 2 months (four
patients), 3 months (one patient), and 8 months (one patient)
after presentation in the other patients. Pathologic findings in
each biopsy specimen are shown in Table 2. There were 13
patients with 1+ DMH, 11 with 2+ DMH, and 5 with 3+ DMH.
The incidence of different grades of mesangial hypercellularity
in females and males is shown graphically in Figure 5. Though
not statistically significant, it is interesting to note that 23% of
males, but only 8% of females, had 3+ DHM. Other than
mesangial hypercellularity, no glomerular changes were noted
although tubulo-interstitial damage was present in nine patients.
Immunofluorescence studies were performed in 28 of 29
patients; ten were positive. Four patients had only mesangial
staining: one with FRA, one with 1gM, one with C3 and 1gM,
and one with C4 and FRA. Four had capillary ioop staining: two
with FRA, one with 1gM, and one with C3. One had mesangial
FRA and capillary C4. In all, three out of 28 initial biopsy
specimens (9%) tested for 1gM were positive. Except for one
patient who had arteriolar staining for C3, no extraglomerular
positive immunofluorescence was found in any of the biopsy
specimens.
Electron microscopy (EM) was performed on the biopsy
specimens of 28 of 29 patients. Biopsy specimens from four
patients contained electron dense deposits: three within the
mesangial matrix and one in a subepithelial location. The
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Fig. 4. Age and sex distribution of children
with idiopathic nephrotic syndrome and
diffuse mesangial hypercellularity. Symbols
are: , males, mean age 6.4; , females,
mean age 6.8. The overall mean age is 6.6.
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Table 2. Pathologic features and response to treatment in patients with idiopathic nephrotic syndrome and diffuse mesangial hypercellularity







1 3+ 0 0 0 N N/— Nephrotic
2 3+ MesIgM Mes 0 N — NFU
3 3+ 0 ND 0 — — Normal
4 3+ Mes FRA
Cap C4
Mes 0 N N/— Normal
5 3+ Mes C4
Mes FRA
Mes 0 N —/N Normal
6 2+ Cap 1gM Subepi 0 N N/— Nephrotic
7 2+ Art C3 0 0 C — Normal
8 2+ 0 0 0 C — Normal
9 2+ 0 0 1+ P — Prot
10 2+ 0 0 2+ N — Nephrotic
11 2+ 0 0 0 — — NFU
12 2+ 0 0 1+ C — Normal
13 2+ 0 0 0 U U Normal
14 2+ ND 0 1+ — — Prot
15 2+ 0 0 0 C — Normal
16 2+ 0 0 1+ — — Prot
17 1+ 0 0 0 N — Prot
18 1+ 0 0 0 N NI— Nephrotic
19 1 + Cap C3 0 0 C — Normal
20 1+ 0 0 0 C — Normal
2la 1+ 0 0 3+ P P/C Normal
b FSGS 0 0 3+ — —
22a 1 + 0 0 2+ P/C — Normal
b 0 0 0 2+ — —
23a I + Cap FRA 0 0 C P/C Nephrotic
b 2+ 0 0 1+ —
24 1+ 0 0 0 C C/— Normal
25 1+ 0 0 0 N —/N Nephrotic
26 1+ MesC3
Mes 1gM
0 1+ P — NFU
27a 1+ Cap FRA 0 0 C —IC Normal
b 0 0 0 0 —
28 1+ 0 0 0 C — Normal
29 1 + Mes FRA 0 0 C — Normal
Abbreviations and symbol: Mes, mesangial; Subepi, subepithelial; FRA, fibrin(ogen)-related antigens; Cap, capillary loop; Art, arteriole; TI,
tubulo-interstitial damage; N, none; ND, not done; NFU, no follow-up; Prot, proteinuria; —, notgiven; u, unknown; Cyclo, cyclophosphamide;
Chlor, chiorambucil; P, partial; C, complete; a, initial biopsy; b, second biopsy; 0, no abnormality seen; FSGS, focal segmental glomerulosclerosis.
three small glomerular electron dense deposits in one capillary
loop out of three glomeruli examined. The three patients with
mesangial electron dense deposits had 3+ DMH; all had
mesangial deposits by IF. However, in two patients with
mesangial deposits by IF, no deposits were noted on EM. Foot
process effacement affecting 70 to 80% of the capillary surface
area studied was seen in every initial biopsy specimen. No
other ultrastructural abnormalities were noted.
Follow-up renal biopsies were performed on four patients.
One patient (no. 21 in Table 2) was found to have focal
segmental glomerulosclerosis 1 year after the original biopsy.
The first biopsy specimen had shown 1+ DMH, 3+ tubular
atrophy but no FSGS. It had been serially sectioned and
contained 29 glomeruli, some of which were juxtamedullary.
The second biopsy specimen contained 42 glomeruli. Immuno-
fluorescence studies were negative and no electron dense
deposits were demonstrated on either biopsy. A repeat biopsy
in patient no. 23, 1.5 years after an initial diagnosis of I + DMH,
showed 2 + DMH and an increase in tubulo-interstitial damage
from 0 to 1+. Initially, this patient responded to steroids, but
had five relapses and was treated with cyclophosphamide
followed by chiorambucil; 33 months after the initial biopsy, the
patient was still edematous and had 4+ proteinuria. Two
patients (numbers 22 and 27) had 1 + DMH on an initial biopsy
and, 1.5 years later, repeat renal biopsy specimens showed no
evidence of DMH. Both patients were free of proteinuria and
had normal renal function at 34 and 47 months of follow-up,
respectively. An adequate sample of tissue was present in both
biopsy specimens obtained from these patients (at least 18
glomerulilbiopsy for light microscopy).
Pathologic correlations. The presence of glomerular electron
dense deposits was associated with 3+ DMH (P = 0.002) and
with positive IF (P = 0.003); however, only four out of the 28
patients had electron dense deposits. Three of the four had
severe grades of DMH (3+) and all had positive IF. No
correlation was demonstrated between tubulo-interstitial dam-
age (nine patients) and any other pathologic finding, including
the presence of positive IF.
Clinico-pathologic correlations. Significant correlations were
found between higher degrees of hematuria and grade of DMH
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(P = 0.038), decrease in GFR and presence of tubulo-interstitial
damage (P = 0.0122), higher serum protein concentrations and
presence of tubulo-interstitial damage (P = 0.0002), and be-
tween the absence of hypertension and presence of positive IF
(P = 0,0007).
Response to treatment
Response to steroid therapy could be evaluated in 24 of 25
treated patients (Table 2); one was lost to follow up. In most
patients, initial prednisone therapy was given in a daily dosage
of 60 mg/rn2 or 2 mg/kg for 1 month followed by alternate-day
prednisone in reduced dosage for 1 or more months. Twelve
patients had complete remissions and one had a partial remis-
sion during prednisone therapy. Two had partial remissions
following bolus methylprednisolone therapy. Nine patients
were resistant to steroid therapy. None of the four patients with
3+ DMH who were treated responded to steroid therapy. Three
of these four patients had positive immune deposits of 1gM, C4,
or FRA together with mesangial or paramesangial electron
dense deposits ultrastructurally. Only one of the five patients
with 1 + or 2+ DMH who failed to respond to therapy had focal
1gM deposits. Seven patients whose biopsy specimens had
positive IF (C3 and 1gM in one, C3 in two, FRA in three, and
1gM in one) without glomerular electron dense deposits, re-
sponded with either complete or partial remissions during
steroid therapy. Two of four patients treated symptomatically
had complete remissions.
Ten patients received a course of cyclophosphamide, chlo-
rambucil, or both (Table 2). Six patients resistant to steroids
were also resistant to either cyclophosphamide (four) or to
chlorambucil (two). Two patients, who relapsed frequently on
steroid therapy, had complete remissions during cyclophospha-
mide or chlorambucil therapy. One patient who had a partial
remission during steroid therapy and one who became resistant
to steroids after an initial response had partial remissions during
cyclophosphamide therapy followed by complete remissions
after chiorambucil therapy.
Clinico-pathologic correlations with response to therapy.
Failure to respond to prednisone therapy was associated with
greater urinary protein excretion (P = 0,04), higher grades of
DMH (P = 0.03), presence of glomerular electron dense depos-
its (P = 0.02), and lower, albeit normal, serum C3 concentra-
tions (P = 0.01). Table 3 depicts the variation in steroid
responsiveness of patients with different grades of DMH.
Failure to respond to cyclophosphamide correlated directly




Grade of mesangial hypercellularity
1+ 2+ 3+
Complete 8 4 0
Partial 2 1 0
None 3 2 4
with previous steroid resistance (P = 0.0004) and with the
amount of proteinuria (P = 0.03), and inversely with the serum
protein concentration (P = 0.03).
Follow-up data
Data are available from 26 patients who were followed for
periods of time ranging from 1 to 90 months (mean, 29 months).
No evidence of renal disease was detected in 16 patients at their
last examination (Table 2); their mean duration of follow-up was
30 months. Edema was present in six patients at their latest
follow-up examination with proteinuria from 1 + to 4+ being
observed in a total of ten patients. Proteinuria in four of these
patients ranged from 21 to 690 mg/m2/hr. Microscopic hematu-
na was present in four of the ten patients with proteinuria.
Chronic renal failure occurred in patient no. 25 after 22 months
of follow-up (serum creatinine 7.9 mg/dl); an elevated serum
creatinine (1.1 mg/dl) was also observed in patient rØ, 10 at 42
months after the onset of INS, and mildly elevated blood
pressure was present in two patients (6 and 23).
Clinico-pathologic correlations with clinical course. No sig-
nificant correlations could be demonstrated between any initial
clinico-pathologic feature and the subsequent clinical course.
Of the six patients with persistent nephrotic syndrome, one had
3+ DMH, two had 2+ DMH, and three had 1+ DMH. Of the
five patients with 3 + DMH, four were treated with prednisone.
Although none of these four patients initially responded to
prednisone, two have subsequently shown spontaneous remis-
sions, one has persistent NS but no renal insufficiency and one
has been lost to follow up. The fifth patient with 3 + DMH did
not receive prednisone but also had a spontaneous remission.
Persistence of proteinuria (ten patients) with or without edema,
at the latest follow-up examination, was correlated with initial
resistance to steroid therapy (P = 0.03).
Discussion
Diffuse mesangial hypercellularity has been associated with
several clinical syndromes including INS [2—7, 15], recurrent
hematuria [16, 171, and the recovery phase of acute poststrepto-
coccal glomerulonephritis [18—23]. DMH associated with INS
was initially described by Churg [2], and White, Glasgow, and
Mills [3]. Several studies have reported pure mesangial prolifer-
ative lesions in 2 to 8% of patients with INS [2—4, 10, 24]. The
incidence of DMH in childhood INS has been reported recently
by the International Study of Kidney Disease in Children
(ISKDC) to be 3% [10]. A survey of the SPNSG experience
from 1972 through 1981 revealed a total of 2829 renal biopsies.
There were 1053 biopsies performed in nephrotic children of
which 29 showed DMH (2.8%). It should be noted, however,
that this incidence rate is based on a selected group of patients











Fig. 5. Distribution of different grades of diffuse mesangial hypercellu-
larity in females, males, and the overall group. Symbols denoting
grades of diffuse mesangial hypercellularity: , 1+;, 2+; E, 3+.
Females (12) Males (17) Overall (29)
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The true incidence of DMH (as defined in this study) in
childhood INS is probably much lower.
One of the main difficulties in evaluating patients with INS
and DMH involves the delineation of precise criteria for diagno-
sis and classification of the histopathologic lesion. We have
adopted the WHO definition of DMH [14] and used a standard-
ized semiquantitative system for grading mesangial hypercellu-
larity [61. We believe that this approach has provided the basis
for a meaningful evaluation of clinico-pathologic correlations
within our own patient population. However, the lack of
conformity between our pathologic criteria and those used in
other studies renders comparisons difficult. The relatively high
incidence rates of hematuria (89%) and hypertension (46%) in
our patients compared to those reported by the ISKDC (44 and
9%, respectively) [10] and others [4, 5, 7, 9] may well reflect the
different histopathologic criteria used in these various studies.
Increased severity of hematuria in our patients was associat-
ed with higher grades of DMH and poor initial response to
steroids and may be an important clinical feature in this group
of nephrotic children. Initial resistance to steroid therapy was
also associated with higher grades of DMH on light microscopy
and with the presence of dense deposits on electron microsco-
py. On the other hand, positive IF was uncommon in our series
and when present did not correlate well with response to
steroids. This is in contrast to a recent report by Allen et al [11]
but in agreement with the work of Schoeneman, Bennett, and
Greifer [18].
Response of INS associated with DMH to prednisone and
cytotoxic drugs such as cyclophosphamide has been variable [2,
3, 5—9]. Despite early resistance to both steroids and cytotoxic
drugs, six of seven patients reported by White, Glasgow, and
Mills [3] ultimately recovered without evidence for INS. Brown
et al [7] reported remissions in three steroid-dependent and two
steroid-resistant patients during cyclophosphamide therapy.
Complete remissions were also described by Siegel et al [91 in
nine children with mesangial proliferation associated with INS.
Garin et al [25] have suggested that children with INS who are
steroid responsive will have a better effect from cyclophospha-
mide than steroid-dependent patients. In our study, 15 out of 24
children (63%) responded with a complete or partial remission
during prednisone or bolus methyiprednisolone therapy. No
response to either cyclophosphamide or chiorambucil therapy
was observed in six steroid-resistant patients. Response to
cyclophosphamide and/or chlorambucil occurred only in the
four patients who had responded previously to steroids. Despite
initial unresponsiveness to steroids in 46%, only one of 11
patients with INS and DMH reported by the ISKDC had
persistent proteinuria 1 year after starting treatment [10]. Our
findings and those of the ISKDC study would suggest that
therapy with cyclophosphamide or chlorambucil is probably
unwarranted in patients with DMH who are steroid
unresponsive.
No evidence of renal disease was detected in 16 of 26 patients
after they were followed for a mean duration of 29 months. Six
of nine children who showed initial complete resistance to
steroids were found to have persistent proteinuria at their most
recent follow-up examination. This persistence of proteinuria,
with or without overt nephrotic syndrome, was associated with
initial resistance to steroids (P = 0.03) but not with severity of
DMH. At the latest follow-up, serum creatinine was elevated in
two of the patients with proteinuria. In addition, two patients
who were initially steroid responsive and two who were treated
symptomatically have minor degrees of proteinuria after 4 to 59
months of follow-up. Brown et al [7] described follow-up
evaluations in eight children ranging from 15 to 156 months
(mean, 70 months); only one child continued to experience
steroid-responsive relapses; none was hypertensive or has
developed evidence of chronic renal insufficiency.
The relationship between DMH, nil lesion and FSGS remains
unclear. Waldherr et al [26] suggested that these three entities
represent a continuum and that over time DMH may convert to
normal, minimal change or FSGS, This apparent transition from
DMH to FSGS has been noted previously [4, 27—30]. In our
study, repeat biopsies in four showed normal glomerular histol-
ogy in two, FSGS in one, and persistence of DMH in the fourth.
It should be noted, however, that the small number of patients
in whom repeat biopsies were performed precludes definite
conclusions at this time.
In summary, our limited follow-up data, as well as those
reported in several other studies [3, 5—10], suggest that children
with INS and DMH generally have a good prognosis despite
early steroid resistance, severe degrees of DMH, or the pres-
ence of EM/IF deposits. Although this retrospective study of
children with INS associated with DMH has provided a number
of important clinico-pathologic correlations regarding the initial
clinical course of such patients, it should be emphasized that
the interim conclusions concerning outcome or prognosis
reached in this study are based on a relatively short period of
follow-up. The subsequent long-term clinical course of INS and
DMH will be evaluated prospectively in the patients presented
herein. In this way, it is anticipated that more definitive
conclusions regarding the prognostic importance of subdividing
histopathologic types of DMH and defining initial steroid re-
sponsiveness may be forthcoming.
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